http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
연잎분말을 첨가한 밥의 품질특성 및 연잎쌈밥의 저장 중 향기성분
박복희 ( Bock Hee Park ),김성두 ( Sung Doo Kim ),전은례 ( Eun Raye Jeon ),조희숙 ( Hee Sook Cho ) 한국식생활문화학회 2012 韓國食生活文化學會誌 Vol.27 No.4
We investigated the quality characteristics and volatile flavor components in yenipsambab prepared with various concentrations of lotus leaf powder. Hunter`s color L and a values of yenipsambab decreased with increasing content of lotus leaf powder, whereas b value increased. Moreover, addition of lotus leaf powder resulted in increased hardness, adhesiveness, chewiness, and brittleness compared to control. Major volatile compounds of yenipsambab were ethyl benzene, 1,3-dimethylbenzene, 1,2-dimethylbenzene, and 5-hydroxymethyldihydrofuran-2-one.
김도형,양재욱,박세광,김성두,허준,윤일한,최인학,Do-Hyung Kim,Jae-Wook Yang,Seh-Kwang Park,Sung-Doo Kim,Jun Hur,Ill-Han Yoon,In-Hak Choi 대한안과학회 2005 대한안과학회지 Vol.46 No.8
Purpose: Transforming growth factor (TGF)-β is recognized as being associated with cataractogenesis. We quantitated the mRNA expression of TGF-β isoforms in cataractous crystalline lens to determine the effect of the isoforms on cataractogenesis. Methods: With lens epithelial cells from thirty eyes in thirty patients, the mRNA expressions of TGF-β1, β2 and β3 were quantitated by real-time SYBR Green polymerase chain reaction and the results were compared according to cataract type and presence of diabetes mellitus. Results: Each isoform mRNA of TGF-β was expressed: TGF-β3 in all 30 eyes, TGF-β1 in 29 eyes (96.7%), with the exception being one diabetic senile cataract, and TGF-β2 in 9 eyes. The amount of TGF-β1 mRNA expression was significantly lower in the diabetic cataracts than in the non-diabetic cataracts (P=0.056). Conclusions: TGF-β was associated with cataractogenesis. It is significant that the expression of TGF-β2 mRNA was decreased in all cataracts. The decrease of TGF-β1 mRNA expression was more meaningful in the diabetic cataracts than in the non-diabetic cataracts.
증례 : 혈액종양 ; 급성 A형 간염의 합병증으로 발생한 혈구포식증후군 1예
박영훈 ( Young Hoon Park ),김대영 ( Dae Young Kim ),김성두 ( Sung Doo Kim ),이정희 ( Jung Hee Lee ),이제환 ( Je Hwan Lee ),이규형 ( Kyoo Hyung Lee ) 대한내과학회 2011 대한내과학회지 Vol.80 No.2S
A형 간염바이러스에 유발된 혈구포식증후군은 드물지만, 발생할 경우 심각한 임상경과를 보인다. 본 저자들은 A형 간염바이러스에 의해 유발된 혈구포식증후군에 대한 치료와 2년간의 추적관찰의 결과를 보고한다. 이전 특이병력이 없었던 24세 여자 환자로 급성 A형 간염으로 진단받고 보존적 치료 중 간 기능 악화 및 수혈에 교정되지 않는 빈혈 그리고 지속적인 발열의 증상으로 시행한 검사실 및 골수검사상 혈구포식증후군으로 진단되었다. 진단 직후 투여한 덱사메타손 단독요법에 반응이 없어 시클로스포린과 덱사메타손 병합요법을 시행하였고, 이후 증상 및 검사실 소견이 호전되어 치료 시작 한 달 후 퇴원하였다. 이후 특이 증상을 호소하지 않고 있으며, 치료 시작 2년째 면역억제제의 복용 없이 경과관찰 중이다. Virus-associated hemophagocytic syndrome (VAHS) is a severe hematological disease characterized by persistent fever, peripheral blood cytopenia, hyperferritinemia, hypertriglyceridemia, and hemophagocytosis in the bone marrow, spleen, or lymph nodes. Despite the high incidence of viral infections in the general population, VAHS complicated by hepatitis A infection is rare worldwide, and there is no standard treatment for VAHS. Treatments include correcting the peripheral blood cytopenia and controlling the infectious causes and immunosuppression, such as with cyclosporine A and corticosteroids. We report on a patient who was diagnosed with hepatitis A virus-associated VAHS, and has been free of signs and symptoms of VAHS for 2 years with a combination of corticosteroid and cyclosporin A. (Korean J Med 2011;80:S278-S282)